SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
Open Access
- 15 April 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 79 (6), e61
- https://doi.org/10.1136/annrheumdis-2020-217506
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- SARS-CoV-2 and HIVJournal of Medical Virology, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals Of The Rheumatic Diseases, 2020
- Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modelingAsian Pacific Journal of Tropical Medicine, 2020
- Hydroxychloroquine in systemic lupus erythematosus (SLE)Expert Opinion on Drug Safety, 2016